From GP surgeries to hospitals, across every department and discipline, the NHS continues to be in crisis. Backlogs aren’t getting smaller, digital transformation is slow, and waiting lists are perpetually increasing. Despite this, Trusts are reluctant to invest in smarter, faster, more flexible ways of working – and it’s easy to see why.
Historically, Trusts have been burned by technology that creates seemingly endless costs without delivering real, measurable value. What appears to be a cost-effective choice now can all-too-often spiral out of control and cost significantly more than expected. While initial investment or subscription fees are within the budget, the expense of implementation, training, and managing adoption undermine the promised value of the software or hardware.
These hidden costs are sadly common and, in some cases, woven into the business model of technology providers. But the true price isn’t just financial – it’s in how these costs affect patients.
What are the potential hidden costs of speech recognition?
Any on-premise technology comes with inevitable hidden costs. These unavoidable expenses may include infrastructure and IT changes, manual implementation and testing, procuring new devices, and ongoing management and maintenance costs, whether they involve your own IT teams or an external provider. Quickly, the per-user licence fee becomes just one part of your overall costs.
In theory, cloud-hosted technology should mark an end to hidden costs. However, the reality of this is largely dependent on the specifics of your chosen solution.
Frequently, cloud software will still require specific equipment. In the case of speech recognition, this could include specific microphones or headsets. Some providers also charge implementation and training fees in addition to your licensing costs. Even if a provider doesn’t charge these fees, you may need to invest in compatible hardware – many solutions are restricted to certain platforms and operating systems.
Finally, usability and intuitiveness play an important role in the cost of your solution. If a speech recognition solution is difficult to use, constantly inaccurate, and frustrating for your users, this creates a very real financial cost in terms of lost productivity, stressed medical professionals, and a negative impact on your patients. In part, these are the financial consequences of a ‘top down’ solution – one where the benefits to your users aren’t clear or desired, so onboarding and widespread adoption take months or even years.
How hidden costs affect practitioners and patients
The appeal of medical speech recognition is simple: improve the workload and daily routine of clinicians to improve the experience of patients.
The way people capture notes is a prime area for reinvention – and one where the benefits can be numerous. Manually typing reports, or waiting for slow secretarial manual transcription adds time to the patient journey. Checking transcription and retyping into clinical systems can slow this journey even further. The amount of time potentially wasted directly correlates to the frustration of medical professionals, the size of the backlog, and the outcomes patients can expect.
Crucially, hidden costs and complexities directly affect patients. The HSJ recently reported a Trust’s admission that ‘patients suffered harm’ due to the huge follow-ups backlog. Meanwhile, data from The Telegraph shows the number of patients waiting to start treatment in England is 7.7 million and growing. Trusts need an urgent intervention and change to ways of working and reporting. A slow, expensive implementation process only creates yet another delay – another drain on resources that takes away from positively affecting patient outcomes.
Medical speech recognition with no hidden costs
In the most objective terms, Augnito Spectra is cloud-hosted, voice-driven AI speech recognition with no hidden costs. Augnito Spectra runs on your existing desktops, tablets, smartphones and MacOS devices. It’s implemented fast with no need for on-premise infrastructure nor IT changes. And our emphasis on ease of use removes the hard-to-estimate cost of training and driving adoption. Users simply take a guided demonstration or click the solution’s own Product Tour button and get started straight away on any device they want.
At the same time, Augnito Spectra is designed to keep costs down over time. With over 99.9% accuracy for any accent and many medical specialities, Augnito eliminates the hidden costs of checking and proofing reports. And with a voice-driven AI engine, Augnito continually evolves – whether you’re adding new words like new drug names, or receiving free, constant updates as we introduce new features. You can see some of our latest updates in this short video.
Augnito Spectra delivers industry leading speech/voice recognition without hidden costs – and, as a cost-effective, intuitive to use, and accurate option, the benefits are easy to see.
Learn more about Augnito
See how Augnito Spectra is already delivering transformational value – with no hidden costs – for medical professionals across the UK. Request a demo to try Augnito Spectra for 7 days and see the benefits for yourself.
In healthcare, new technology always seems to be promising a faster, smarter, better way of working. Solutions claim they’ll save you time and remove your stress, all while improving outcomes for patients and making their journeys more seamless. But those promises all need to be balanced against a simple, more pragmatic reality: budgets are always limited in the healthcare ‘business’.
Recently, the business of healthcare has been in the spotlight. With rising costs and widespread strikes for NHS workers with more on the horizon, there’s more pressure than ever to spend money effectively. Crucially, this doesn’t mean ceasing all spending. It means targeting your budget where the impact – on healthcare professionals, patients, and outcomes – will be biggest and where the value will be most effective.
With the NHS in crisis, now is the time for change: from overworked professionals burdened by manual reporting to a more agile, flexible way of working. And that transformation doesn’t have to mean huge investment, changes to your IT infrastructure, or expensive training.
The demands on healthcare have intensified
Waiting lists are increasing, hospital bed capacities are shrinking and, according to data from the British Medical Association, the average GP is responsible for 17% more patients on average compared to 2015. Accelerated by the pandemic, the healthcare needs of the UK have dramatically shifted in the past few years. It’s only natural, then, that the way healthcare professionals work needs to shift too.
However, healthcare in general is reluctant to invest in new technology. In a recent study by BT, 49% of NHS staff said the standard of technology at work was a source of stress. But while 29% strongly agree that innovation is hamstrung by a lack of funding, 37% identified cultural resistance to change as a significant barrier.
With this in mind, understanding the true value of new technology is key. The only way to overcome cultural resistance is with an objective approach – one that pits costs and price against value, reconciling the expense of a given technology with the impact on staff and patients.
Measuring the price and cost of AI-enhanced speech recognition
The healthcare industry has generally been willing to invest in AI, but Deloitte identifies the need to measure return on investment as key to continued transformation. AI-enhanced speech/voice recognition (instant digital transcription) gives users a faster, more flexible way to report and capture notes, including direct dictation into existing clinical workflows and applications. This has the potential to deliver a measurable return by saving a considerable amount of time and empowering staff to work efficiently – without compromising accuracy.
Augnito Spectra, our clinical speech recognition software, costs £576 (including VAT) per user, per year. With an average of 260 working days, that’s just £2.22 per day. Given that Augnito Spectra saves on average one hour a day – an hour that brings with it an implied cost – that’s a considerable return on investment. At the same time, Augnito has a positive impact on overworked users, improving not only performance and effectiveness but engagement, and retention. Compared to the costs of missed days due to stress or, worse, having to find someone new when people reach their limit and leave healthcare, Augnito is a significant saving.
For a few pounds per day, Trusts can empower their clinical professionals to work at their best. And that ultimately enables better healthcare outcomes for clinicians and medical staff and for patients – the most valuable output of all.
A speech recognition solution designed to create value
£2.22 per user, per day. That’s less than a pack of Nurofen (and other brands) to fend off the headache of slow, time-consuming reporting. It’s even less than a box of plasters to patch over the workload problem until people leave the healthcare sector.
Augnito Spectra also goes further to create value for your clinical staff and organisation. Designed to go wherever your people do, it includes:
• Mobile speech recognition on iOS or Android devices
• Seamless cloud-based notes, available on any device
• MacOS, Windows and web browser access
• Support for remote workers and sharing reports with different clinical systems
Learn more about Augnito
See how Augnito Spectra is already delivering transformational benefits – and measurable value – for medical professionals across the UK. Request a demo to try Augnito Spectra for 7 days and see the benefits for yourself.
[London, 29 March 2023] – With the NHS struggling to meet the demands of an ageing population, complex discharge processes, and widespread bed shortages, new technology has an important role to play in safeguarding patient outcomes.
The past few years have been incredibly challenging for the NHS, with the pandemic and heightened demand bringing longstanding problems into sharp, urgent focus. Bed shortages continue to be a major issue, with British Medical Association data from December 2022 reporting that occupancy rates consistently exceed safe levels. Meanwhile, Delayed Transfers of Care (DTOCs) create unnecessary bottlenecks, with patients occupying beds when they are clinically ready to be discharged or transferred.
For NHS Trusts, this creates a significant, largely unnecessary cost – one that’s hard to immediately address by adding new bed stocks. That’s why Scribetech, the co-creators of AI speech recognition solution Augnito, are working to help Trusts understand the potential of innovative new technology.
“For decades, the NHS has tried to address bed stock and occupancy issues by adding more beds, but we have consistently seen that it’s almost impossible to keep up with demand” stated Shiraz Austin, Managing Director at Scribetech and Co-Founder of Augnito. “Technology and changes in ways of working have the potential to reduce occupancy rates and improve care in a way that’s more sustainable. But this transformation is only possible if it makes financial sense.”
Estimating the financial cost of DTOCs and the bed shortage is difficult. Department of Health figures put the cost of a DTOC bed at £400/day, while Age UK report 2019 costs of £346/day. Using a forgiving cost of £350/day, this implies a bill in excess of £54 million just for the delayed days in February 2020, when DTOC metrics were last reported.
Speech recognition technology like Augnito can’t immediately eliminate all DTOCs, but it can deliver consistent, incremental improvements to the workflows of multidisciplinary teams (MDTs). With real time dictation and transcription in any platform or dedicated desktop and smartphone applications, healthcare professionals can reduce the risk of delays arising from inaccurate records, lost records, and breakdowns in communication.
Austin continued: “The financial outlook is clear: the cost of new technology is significantly less than the cost of delays and low bed stocks. The cost of a single extra bed per day is 10 times the cost of an Augnito licence for a month. But that commercial reality is just one part of the picture. There’s a human cost that must also be considered.”
While delays and occupied beds affect every patient – and, indeed, the entire healthcare system including social care – some particularly vulnerable groups are disproportionately affected. December 2021 saw intensive care beds for children reach record occupancy of 89% across the country. Meanwhile, older patients are particularly at risk given the typical complexity of their discharge or transfer to other providers.
When paediatric beds simply aren’t available or elderly patients are kept on wards for weeks, even months after they’re ready to be transferred, their experience is resoundingly negative. They’re unable to receive the care that is appropriate, when it is required, in the right setting. In some cases, this comes with a very real and measurable impact on outcomes.
Austin concluded: “Augnito is designed to work for NHS Trusts – a cloud-hosted technology that’s significantly lower in cost than unnecessary delays and can be implemented quickly and easily. But it’s also designed to empower healthcare professionals and multidisciplinary teams to work efficiently, so they can act based on what patients need, without being limited by processes and old, outdated workflows.”
END
Notes to editors
Full blog posts referenced in this media alert:
https://www.scribetech.co.uk/2023/02/28/how-speech-recognition-technology-can-support-a-national-bed-shortage/
https://www.scribetech.co.uk/2023/03/15/reducing-dtoc-on-vulnerable-patients/
For further information, interview opportunities or accompanying graphics please contact: [email protected]
About Scribetech and the Augnito solution – visit https://www.scribetech.co.uk/ for details and follow us on Linked-In.
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99.3% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible wherever it’s needed. Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.
[London, 10 February 2023] – As the NHS continues to address and reduce Delayed Transfer of Care (DTOC) incidents – and their associated costs – speech recognition has the potential to deliver transformative efficiency gains.
With the healthcare system under unprecedented pressure, NHS Trusts are reflecting on key metrics associated with performance, cost, and quality of patient care. Delayed Transfers of Care (DTOCs) see patients continue to occupy beds when they are clinically ready to be transferred or discharged. This results in significant expense to the NHS, a lack of available bed stocks, and disrupted journeys for both the patients waiting for transfer and those waiting for beds.
According to Scribetech, UK distributors of Augnito, a cloud-based, AI-powered speech recognition solution, new technology and workflow transformation have the potential to significantly improve how DTOC is managed.
“DTOCs are an indicator of how healthy the health and social care systems are,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito.ai. “When patients continue to occupy beds they don’t clinically need, there’s a ripple effect that stretches across the patient journey. This includes delays to treatment for new patients, as well as a considerable amount of distress for those needlessly held in hospital.”
The scale of the DTOC problem is significant. In February 2020, reports show, there were an average of 5370 people delayed per day across the NHS in England – some attributable to the NHS, some attributable to social care, and some with joint responsibility. Based on the Department of Health’s reported costs of an excess bed per day (£350 – £400), the estimated cost of DTOC was as high as £2,148,000 per day for that month alone.
However, this immediate financial impact is just one consequence of DTOCs. With bed stocks at an all-time low and occupancy at an all-time high, DTOCs directly affect the availability of treatment, making acute care when a bed is finally available even more costly and negatively affecting patient outcomes.
Innovative new technology has the potential to positively influence these outcomes – but Austin remains realistic about the results.
Austin continued: “It’s not that technology like Augnito can solve the DTOC challenge overnight. It’s that incremental improvements to the way healthcare professionals work, collaborate, and share information eliminate the low-hanging fruit of slow reporting and typing into cumbersome, often outdated, systems. And time saved leads to reduced cost, where budgets can be repurposed into wider, systemic changes.”
Augnito was designed in partnership with healthcare professionals to address their biggest challenges. This includes bringing real-time SR to the clinical systems used as part of the discharge and transfer process, allowing people to work faster and more flexibly.
Adopted widely, Augnito can deliver:
– Faster reporting time and fewer internal delays to patient discharge or transfer
– Reduced costs, which can be repurposed into growing bed stocks and community nursing
– Increased bed availability with less waste and lower occupancy
– A way to offset the removal of the Government’s Covid-19 DTOC funding
As standard, Augnito empowers healthcare professionals with advanced SR on any device – desktops, web browsers, and mobiles. With a flexible SDK and API, Augnito can also be integrated into existing systems for accurate, immediate capture into an Electronic Patient Record.
Based on February 2020 DTOC data, just a small reduction in turnaround time, inaccuracies and errors could save the NHS hundreds of thousands per month. Austin concluded: “Augnito creates a more seamless way of working for healthcare professionals, helping with considerable workloads and backlogs. But its real impact is on the NHS as a whole, improving financial drainage and removing the bottlenecks that become obstacles to outstanding patient care and the best possible outcomes.”
END
Notes to editors
Read the full blog post here www.scribetech.co.uk/2023/01/31/can-the-advantages-of-clinical-voice-ai-sr-technology-help-reduce-dtoc
For further information, interview opportunities or accompanying graphics please contact: [email protected]
About Scribetech and the Augnito solution – visit https://www.scribetech.co.uk/ for details and follow us on Linked-In.
About Augnito India Private Limited – visit Augnito.ai.
[London, 31 January 2023] – Scribetech has been re-appointed to the NHS Commercial Solutions Framework Agreement for the provision of digital dictation, speech/voice recognition, outsourced transcription and associated services in all four of the authority’s lots.
Scribetech (UK) Ltd has been re-awarded its third consecutive listing, since 2010, on the NHS Commercial Solutions Framework following the contracting authority’s comprehensive information gathering and tender evaluation process.
Scribetech will see its Textflow digital dictation solution and Augnito voice-AI speech recognition products offered to all NHS organisations.
The four lots under the NHS Commercial Solution framework agreement for which a product or services provider is invited to tender include: Products and/or Services Catalogue; In-house and Outsourced Digital Dictation Service Solution, Outsourced Transcription Service Solution, and Managed Service Solution.
Formed in 2007, and based in the South East of England, the NHS Commercial Solution Framework is a non-profit procurement shared services hub providing collaborative solutions and end-to-end services that combine data analytics and its dedicated category specialists’ in-depth knowledge of supply markets to address stakeholder needs. Categories include: corporate services, digital, estate and facilities, pharmacy, workforce and staffing, and clinical. These services are offered and provided across the NHS and the wider public sector, supporting acute, mental health, community, ambulance trusts, and commissioning organisations.
To date, NHS Commercial Solutions has saved in excess of £230 million for its customers, based on year one project savings alone.
Scribetech has long been recognised as a pioneering clinical transcription services and medical documentation company that has consistently ranked top on multiple NHS Framework contracts since 2005. “We are extremely pleased with the NHS Commercial Solutions award. It validates not only Scribetech’s vision and our digital dictation technology and voice-AI capabilities, but the ability to provide NHS organisations with cost-effective solutions that really do address many of the core issues that confront medical professionals on the healthcare frontline, such as improving efficiency and accuracy, as well as optimising clinical workflows, resources and budgets.” commented Shiraz Austin, Co-Founder of Augnito and Managing Director at Scribetech (UK) Ltd.
“Scribetech was founded to provide acutely accurate, efficient, cost-effective, outsourced and in-house services and technology to support NHS clinical transcription. Augnito was developed as a result of 20 years of hands-on-experience delivering such services. Combining our digital dictation, transcription and speech recognition voice-AI offering as an augmented clinical administration solution is where we believe NHS organisations will start to see their digital transformation garnering the positive results they critically need across all care departments” concluded Austin.
END
Notes to editors
For further information, interview opportunities or accompanying graphics please contact: [email protected]
About Scribetech Textflow and Augnito
Visit https://www.scribetech.co.uk/ for more details.